Research map: Optimizing Study Design for Clinically Useful Peripheral Molecular Biomarker Discovery in Psychiatry

Back to the article

Papers in this map

  1. The UK Biobank resource with deep phenotyping and genomic data · Clare Bycroft · 2018 · 10126 citations · Cited by this paper
  2. Error in Table · 2026 · Related
  3. The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions · Irving I. Gottesman · 2003 · 5670 citations · Cited by this paper
  4. Medication and Procedural Abortion and Risk of Psychotropic Medication Use · 2026 · Related
  5. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup · Clifford R. Jack · 2024 · 2682 citations · Cited by this paper
  6. Assessing Drug Efficacy After Multiple Negative Trials—Gepirone’s Journey Through the FDA · 2026 · Related
  7. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program · Daniel Taliun · 2021 · 2383 citations · Cited by this paper
  8. Electroencephalography Microstates—A Biomarker for Psychosis? · 2026 · Related
  9. Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population · Jonna Perälä · 2007 · 1533 citations · Cited by this paper
  10. Deconstructing Social Functioning in Psychosis Risk—From Prediction to Recovery · 2026 · Related
  11. Early brain development in infants at high risk for autism spectrum disorder · The IBIS Network · 2017 · 1185 citations · Cited by this paper
  12. Confounding and Circularity in Actigraphy Prediction · 2026 · Related
  13. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? · Shitij Kapur · 2012 · 1020 citations · Cited by this paper
  14. Psychedelics Trials and Outcomes—A Closer Look—Reply · 2026 · Related
  15. A tutorial on conducting genome‐wide association studies: Quality control and statistical analysis · Andries T. Marees · 2018 · 914 citations · Cited by this paper
  16. JAMA Psychiatry · 2026 · Related
  17. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies · David Broadhurst · 2018 · 914 citations · Cited by this paper
  18. Connectivity- vs Scalp-Based Targeting of Accelerated Transcranial Magnetic Stimulation for Depression · 2026 · Related
  19. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers · Brett A. Clementz · 2015 · 790 citations · Cited by this paper
  20. Error in Visual Abstract · 2026 · Related
  21. Large-scale plasma proteomics comparisons through genetics and disease associations · Grímur Hjörleifsson Eldjárn · 2023 · 590 citations · Cited by this paper
  22. Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes · Eilis J. Hannon · 2015 · 499 citations · Cited by this paper
  23. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood · Ting Qi · 2018 · 481 citations · Cited by this paper
  24. The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence · Mauricio F. Tohen · 2003 · 471 citations · Cited by this paper
  25. A reference map of potential determinants for the human serum metabolome · Noam Bar · 2020 · 470 citations · Cited by this paper
  26. Candidate biomarkers in psychiatric disorders: state of the field · Anissa Abi‐Dargham · 2023 · 380 citations · Cited by this paper
  27. Probability of Transition to Psychosis in Individuals at Clinical High Risk · Gonzalo Salazar de Pablo · 2021 · 372 citations · Cited by this paper
  28. Autism-related dietary preferences mediate autism-gut microbiome associations · Chloe X. Yap · 2021 · 371 citations · Cited by this paper
  29. Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome · Lianmin Chen · 2022 · 330 citations · Cited by this paper
  30. Painting a new picture of personalised medicine for diabetes · Mark I. McCarthy · 2017 · 263 citations · Cited by this paper
  31. Prospective Longitudinal Studies of Infant Siblings of Children With Autism: Lessons Learned and Future Directions · Péter Szatmári · 2016 · 260 citations · Cited by this paper
  32. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis · Dan J. Siskind · 2021 · 259 citations · Cited by this paper
  33. Proteomic signatures improve risk prediction for common and rare diseases · Julia Carrasco-Zanini · 2024 · 239 citations · Cited by this paper
  34. Reliability of Lifetime Diagnosis · Nancy C. Andreasen · 1981 · 222 citations · Cited by this paper
  35. Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management · Jennifer Kirwan · 2022 · 210 citations · Cited by this paper
  36. Widespread signatures of natural selection across human complex traits and functional genomic categories · Jian Zeng · 2021 · 168 citations · Cited by this paper
  37. Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms · Danielle E. Haslam · 2022 · 153 citations · Cited by this paper
  38. DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia · Eilis J. Hannon · 2021 · 146 citations · Cited by this paper
  39. Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration · Lisa M. McShane · 2013 · 140 citations · Cited by this paper

Source: OpenAlex (CC0)